Nuzenio

Zevra Therapeutics

Zevra Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 10:47:29 GMTWhy Zevra Therapeutics (ZVRA) Is Up 21.6% After Strong MIPLYFFA Uptake And New Real-World Data - simplywall.st
Sat, 08 Aug 2026 07:01:13 GMTZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today? - Stocktwits
Sat, 08 Aug 2026 04:10:38 GMTMaxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $35 - Moomoo
Fri, 07 Aug 2026 20:19:32 GMTZevra Therapeutics, Inc. (ZVRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Fri, 07 Aug 2026 11:33:13 GMTsymbol__ Stock Quote Price and Forecast - CNN
Fri, 07 Aug 2026 05:12:00 GMTWhat Could Zevra Therapeutics (ZVRA) New NPC Data Mean For Its Europe Review? - Yahoo Finance

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Zevra Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.